In line with the results of the present study, a meta‐analysis of 10 randomized controlled clinical trials that examined the efficacy of pro/synbiotic supplementation among adults with MetS showed no significant differences in FBS, insulin, and HOMA‐IR between the intervention and placebo groups (Hadi et al., 2021). This evidence concerns the gene INS and metabolic syndrome.